Navigation Links
Pharmaceuticals - Global Group of Eight (G8) Industry Guide
Date:5/23/2012

als market in France, 2010 64Figure 29: Drivers of degree of rivalry in the pharmaceuticals market in France, 2010 66Figure 30: AstraZeneca PLC: revenues & profitability 71Figure 31: AstraZeneca PLC: assets & liabilities 71Figure 32: GlaxoSmithKline Plc: revenues & profitability 76Figure 33: GlaxoSmithKline Plc: assets & liabilities 76Figure 34: Pfizer Inc.: revenues & profitability 79Figure 35: Pfizer Inc.: assets & liabilities 79Figure 36: France pharmaceuticals market value forecast: $ million, 2010–15 80Figure 37: Germany pharmaceuticals market value: $ million, 2006–10 84Figure 38: Germany pharmaceuticals market segmentation: % share, by value, 2010 85Figure 39: Germany pharmaceuticals market share: % share, by value, 2010 86Figure 40: Forces driving competition in the pharmaceuticals market in Germany, 2010 87Figure 41: Drivers of buyer power in the pharmaceuticals market in Germany, 2010 88Figure 42: Drivers of supplier power in the pharmaceuticals market in Germany, 2010 90Figure 43: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2010 92Figure 44: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2010 94Figure 45: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2010 96Figure 46: GlaxoSmithKline Plc: revenues & profitability 102Figure 47: GlaxoSmithKline Plc: assets & liabilities 102Figure 48: Novartis AG: revenues & profitability 105Figure 49: Novartis AG: assets & liabilities 106Figure 50: Pfizer Inc.: revenues & profitability 109Figure 51: Pfizer Inc.: assets & liabilities 109Figure 52: Germany pharmaceuticals market value forecast: $ million, 2010–15 110Figure 53: Italy pharmaceuticals market value: $ million, 2006–10 114Figure 54: Italy pharmaceuticals market segmentation: % share, by value, 2010 115Figure 55: Italy pharmaceuticals market share: % share, by value, 2010 116Figure
'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , June 18, 2013  In a letter to ... , M.D., of Lake View, Iowa , ... receive annual influenza vaccine is neither scientifically justified nor ethically ... article in the summer issue of the Journal ... official statistics are correct, and an average of 36,000 patients ...
(Date:6/18/2013)... Decision Resources, one of the world,s leading research and advisory ... past 12 months, 25 percent of surveyed physicians from the ... , Italy , Spain ... been required to change the antiretroviral (ARV) prescription for some ... Additionally, more than 40 percent of respondents report that changing ...
(Date:6/18/2013)... June 18, 2013 New-generation electronic designs ... portable and lightweight. Simultaneously, circuitry is increasing the ... speed to which it performs at. Connecting cables ... and military equipment, such as cameras or detectors, ... and nano-circular connectors include custom cable designs for ...
Breaking Medicine Technology:Mandated Flu Vaccine for Hospital Workers Ethically Questionable, Surgeon Writes 2One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 2One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 3Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility 2
... , ABBOTT PARK, Ill., Nov. 12 Nearly one in ... normal and nearly 34 million have low HDL "good" cholesterol ... HDL and trigs, Abbott has launched two Web sites: ... , "Unhealthy high triglyceride and low HDL levels are factors ...
... a leader in fluorescence in vivo imaging from ... new Cat B 750 FAST(TM) imaging agent for ... and therapeutic response in vivo . Cathepsin B ... target in a range of diseases, including atherosclerosis, oncology, and ...
Cached Medicine Technology:New Web Sites Educate About Triglycerides and HDL Cholesterol 2VisEn Launches New Cat B 750 Fast(TM) Fluorescence Molecular Imaging Agent at American Heart Association Meeting 2VisEn Launches New Cat B 750 Fast(TM) Fluorescence Molecular Imaging Agent at American Heart Association Meeting 3
(Date:6/18/2013)... have discovered and mapped the signaling network between two ... could cut off cancer cell growth at its starting ... University of Texas MD Anderson Cancer Center reported the ... cancer drug target, and MCM7, a protein vital to ... issue of Cancer Cell . , "MCM7 overexpression ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 The July 2013 ... Cheater’s Guide to Getting Beach Ready,” offers a list of ... look their best in a bathing suit this summer. The ... skin firming , smoothing cellulite , and more. (go ... Ourian, Medical Director of Epione Beverly Hills, “though I would ...
(Date:6/18/2013)... June 18, 2013 myCNAjobs announces the ... free downloads, articles, and tips to the Caregiver Resources ... care for the 10,000+ retiring baby boomers each day, ... caregiver job resources has never been greater. ... job community, recently launched the first-ever free resource ...
(Date:6/18/2013)... June 18, 2013 Healthcare ... ScripNet and Procura Management, today announced the appointment ... sales officer. In this position, Leonardo will direct ... the company’s strategic growth initiatives. , Recognized in ... and expertise, Leonardo brings more than 20 years ...
(Date:6/18/2013)... June 18, 2013 Today, Zane Benefits, ... Reimbursement Accounts . Zane Benefits, which provides comprehensive and ... the leader in defined contribution and ... Benefits’ website, employees of a company who sets up ... questions about how Health Reimbursement Accounts work. Educating employees ...
Breaking Medicine News(10 mins):Health News:Scientists catch EGFR passing a crucial message to cancer-promoting protein 2Health News:Skin Care – Getting Your Body Beach Ready 2Health News:myCNAjobs Adds New Resources to Growing Caregiver Career Center 2Health News:Healthcare Solutions Appoints Richard Leonardo to Chief Sales Officer 2Health News:Zane Benefits Publishes New Information on Health Reimbursement Accounts 2
... 8 Pieris AG,a biopharmaceutical company developing Anticalins(R), ... announced the appointment of Dr,Angelika Stern as Chief ... the promotion with immediate effect of Dr Andreas ... Preclinical Development to Chief,Technology Officer. The appointment ...
... November 8 - Healthcare Businesswomen,s ... Groundbreaking Study and Best Practices for,Recruitment, Retention, ... the highly anticipated Healthcare Businesswomen,s,Association (HBA) E.D.G.E. ... exceeded the expectations of pharmaceutical senior,management, who ...
... Cell Therapeutics, Inc. (CTI),(Nasdaq and MTAX: CTIC) today reported recent ... September 30, 2007. Recent Events, -- Announced agreement ... first FDA-approved radioimmunotherapy, from Biogen Idec; this ... group of only a few biotech ...
... - Revenue for the third quarter was $464.6 million, Facility Operating ... - Average occupancy for the quarter was 90.8%, and average revenue per, ... ... quarter.,- Cash From Facility Operations for the quarter was $43.3 million, or $0.43, ...
... Leader Joins Healthcare ... Management Consulting Practice, SANTA ANA, Calif., ... appointment of Ogan Gurel, M.D. as a Managing,Director with its ... join our team," said Vip Jain - Principal and,Head of ...
... Inc. (OTC,Bulletin Board: GOVX), an Atlanta based biotechnology ... Ph.D. has been elected,"Fellow of the American Association ... "Fellow" is an honor bestowed upon AAAS members ... science or its,applications. Emory University professor and Asa ...
Cached Medicine News:Health News:Pieris Strengthens its Management, as it Prepares for the Clinical Development of PRS-050, an Anticalin(R)-Based Novel Cancer Therapy 2Health News:Pieris Strengthens its Management, as it Prepares for the Clinical Development of PRS-050, an Anticalin(R)-Based Novel Cancer Therapy 3Health News:E.D.G.E. in Leadership Study Delivers First-Ever Data on Executive Women in Pharmaceutical and Biotech Industries 2Health News:E.D.G.E. in Leadership Study Delivers First-Ever Data on Executive Women in Pharmaceutical and Biotech Industries 3Health News:E.D.G.E. in Leadership Study Delivers First-Ever Data on Executive Women in Pharmaceutical and Biotech Industries 4Health News:E.D.G.E. in Leadership Study Delivers First-Ever Data on Executive Women in Pharmaceutical and Biotech Industries 5Health News:Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and Third Quarter 2007 Financial Results 2Health News:Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and Third Quarter 2007 Financial Results 3Health News:Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and Third Quarter 2007 Financial Results 4Health News:Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and Third Quarter 2007 Financial Results 5Health News:Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and Third Quarter 2007 Financial Results 6Health News:Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and Third Quarter 2007 Financial Results 7Health News:Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and Third Quarter 2007 Financial Results 8Health News:Brookdale Announces Third Quarter 2007 Results 2Health News:Brookdale Announces Third Quarter 2007 Results 3Health News:Brookdale Announces Third Quarter 2007 Results 4Health News:Brookdale Announces Third Quarter 2007 Results 5Health News:Brookdale Announces Third Quarter 2007 Results 6Health News:Brookdale Announces Third Quarter 2007 Results 7Health News:Brookdale Announces Third Quarter 2007 Results 8Health News:Brookdale Announces Third Quarter 2007 Results 9Health News:Brookdale Announces Third Quarter 2007 Results 10Health News:Brookdale Announces Third Quarter 2007 Results 11Health News:Brookdale Announces Third Quarter 2007 Results 12Health News:Brookdale Announces Third Quarter 2007 Results 13Health News:Brookdale Announces Third Quarter 2007 Results 14Health News:Brookdale Announces Third Quarter 2007 Results 15Health News:Brookdale Announces Third Quarter 2007 Results 16Health News:Brookdale Announces Third Quarter 2007 Results 17Health News:Brookdale Announces Third Quarter 2007 Results 18Health News:Brookdale Announces Third Quarter 2007 Results 19Health News:Brookdale Announces Third Quarter 2007 Results 20Health News:Brookdale Announces Third Quarter 2007 Results 21Health News:XRoads Solutions Group Appoints Dr. Ogan Gurel as Managing Director 2Health News:GeoVax Co-Founder Dr. Harriet Robinson Named 2007 AAAS Fellow 2
Bi-Directional doppler volume flowmeter....
... frequency and multigate transcranial ... and fitted with a ... for hemodynamic evaluation. Looki ... well for routine diagnosis ...
One channel, one gate transcranial Doppler that is diagnosis oriented with an advanced protocol editor, automatic report generator and a powerful examination data base....
One channel transcranial Doppler...
Medicine Products: